Jan 29, 2021 08:30 JST
Olympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities
Strategic acquisition of Dutch multispectral imaging leader drives growth of Olympus' Surgical Endoscopy business
Tokyo / Hamburg, Jan 29, 2021 - (JCN Newswire) - Olympus Corporation (TSE: 7733) today announced that it has entered into an agreement to acquire Quest Photonic Devices B.V. (Quest; CEO: Richard Meester) for up to EUR50 million including milestone payments to strengthen its surgical endoscopy capabilities.
Headquartered in the Netherlands, Quest offers advanced fluorescence imaging systems (FIS) for the medical field, enabling more surgical endoscopy capabilities, compared to conventional imaging technologies.
Fluorescence imaging refers to special light imaging technologies that utilize the properties of fluorescent dyes directed to specific anatomical structures. By using targeted dyes, in combination with specific light wavelengths, tissues or lesions that are nearly invisible under normal white light become visible. Olympus' existing laparoscopic imaging system, VISERA ELITE II, is already equipped with fluorescence imaging technology. VISERA ELITE II uses near-infrared light to identify blood vessels or lymph nodes under the surface tissues, aiming to assist surgeons in performing safer procedures with lower complication risks. The Quest technology acquired is intended to expand opportunities for Olympus in this field.
Making the Invisible Visible
Quest offers innovative technologies for multi-spectral imaging and imaging systems for medical applications, ranging from fluorescence imaging to photodynamic therapy. The acquisition strengthens Olympus' position as a world leader in medical imaging solutions, and delivers innovative capabilities (including 3D and 4K imaging) to surgeons, to "make the invisible visible."
Quest's lead product line is the Quest Spectrum Fluorescence Imaging System, which enables fluorescence-guided surgery for open and minimally invasive procedures. Kanichi Matsumoto, global head of Surgical Endoscopy at Olympus, said: "We are delighted to incorporate Quest's advanced FIS capabilities into our comprehensive medical imaging portfolio. The combination of the Quest Spectrum product line's leading FIS technologies with Olympus' existing laparoscopic imaging system VISERA ELITE II will enable Olympus to offer surgeons a wide range of high-quality fluorescence imaging solutions."
New Applications and Market Growth
The global market for FIS devices is expected to grow at a compounding annual rate of more than 12%, from around US$310 million in 2018 to over US$827 million in 2027*. Increasing demand for minimally invasive procedures and reconstructive surgery is helping to drive FIS growth worldwide. Furthermore, application of the FIS technology is expected to expand over the coming years, as additional fluorescent dyes are paired with targeted antibodies. Among other applications, molecular imaging will allow healthcare professionals to visualize cancerous lesions in vivo and perform cancer surgery in unprecedented ways, potentially lowering recurrence rates.
Quest also works with biotechnology companies that are developing next-generation molecular imaging dyes. These innovative dyes may enable Quest's technology to advance diagnostic opportunities in fluorescence-guided cancer surgery.
*Source: Transparency Market Research; Near-Infrared Fluorescence Imaging System Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2019-2027.
Quest Photonic Devices B.V. is a multispectral imaging leader and focuses on the medical markets of fluorescence image-guided surgery and cancer-targeted probes. Quest's next-generation Spectrum Florescence Imaging System has the ability to "see through tissue" with enhanced sensitivity, capable of accessing otherwise inaccessible information to aid the surgeon in improving clinical outcomes.
About Olympus' Medical business
As a leading medical technology company, Olympus' Medical business uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients and their safety. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments for endoscopic and therapeutic applications. For more information, visit www.olympus-global.com.
For questions or additional information, please contact:
Europe, Middle East and Africa
Japan and Asia Pacific
Sectors: Healthcare & Pharm, MedTech
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
More Latest Release >>
TANAKA to Provide Pure Gold, Pure Silver, and Pure Bronze Medals for the Tokyo Marathon 2024
Feb 21, 2024 04:00 JST
Fujitsu collaborates with QuTech in development of new technology for freezing electronics to control diamond spin qubits
Feb 20, 2024 21:28 JST
NTT DOCOMO and SK Telecom Release White Paper on Base Station Equipment Utilizing Virtualization Technology
Feb 20, 2024 15:32 JST
NEC Develops AI Technology for Robotics Capable of Autonomous and Advanced Handling of Disorderly Placed Items
Feb 20, 2024 12:03 JST
JCB and The Bicester Collection expand their partnership to offer more luxury shopping opportunities for Asian travellers
Feb 20, 2024 12:00 JST
National High School in the Philippines Built with the Support of Mitsubishi Motors Holds Opening Ceremony
Feb 20, 2024 11:15 JST
Eisai Selected for 'Human Capital Leaders 2023' and 'Human Capital Management Gold Quality', Recognized as Company Committed to Excellent Management and Disclosure of Human Capital Initiatives
Feb 20, 2024 09:35 JST
TOYOTA GAZOO Racing Finishes Strongly on Swedish Snow
Feb 19, 2024 19:26 JST
MC to Subscribe Shares in TVS Vehicle Mobility Solution in India
Feb 19, 2024 17:42 JST
NEC Enhances Value Added Network Solution Suite to Boost Enterprise Digital Innovation
Feb 19, 2024 16:05 JST
Fujitsu develops technology to speed up quantum circuit computation in quantum simulator by 200 times
Feb 19, 2024 10:26 JST
MHI Recognized by CDP as Being at the Leadership Level for Climate Change Earning A- score
Feb 19, 2024 10:08 JST
MAZDA INNOVATION SPACE TOKYO Opens
Feb 16, 2024 17:29 JST
NEC develops RAN autonomous optimization technology that dynamically controls 5G networks based on user terminal status
Feb 16, 2024 11:42 JST
Eisai: Metoject Subcutaneous Injection Pen (Methotrexate) Pen-Type Autoinjector Approved in Japan
Feb 16, 2024 09:31 JST
PoC Launched to Test Smart-charging Service Using EV Connected Technologies
Feb 15, 2024 16:50 JST
Hitachi Energy and TransnetBW make German grid fit for future
Feb 15, 2024 11:22 JST
JCB Cards are now accepted at Maybank merchant terminals in Singapore
Feb 15, 2024 11:00 JST
Arsaga Partners, Tokyu Land, NTT and DOCOMO to Explore Collaboration for R&D to Create Services with IOWN
Feb 14, 2024 15:40 JST
TMC Announces Personnel Changes in Senior Management
Feb 14, 2024 13:11 JST